| 2024 |
Chi-Huey Wong, Glycoengineering for a Universal COVID-19 Vaccine, Scientia, vol. Oct 30, 2024, e--pub, 2024 |
| 2024 |
M.-R. Kao, T.-H. Ma, H.-Y. Chou, S.-C. Chang, L.-C. Cheng, K.-S. Liao, J.-J. Shie, P.-J. Harris, C.-H. Wong, Y. S.-Y. Hsieh, A Robust α-l-Fucosidase from Prevotella nigrescens for Glycoengineering Therapeutic Antibodies., ACS chemical biology, vol. 19(7), 1515-1524, 2024 |
| 2024 |
K.-S. Liao, C.-C. Kung, L.-C. Cheng, C. Chung, C.-H. Wong, Synthesis and Quantitative Analysis of Glycans Conjugated to Gold Nanoparticles, Helvetica Chimica Acta, vol. online only, e202300209, 2024 |
| 2024 |
Ozdemir A, (Lin JL, Gulfen M, Chen CH, Advancing mass spectrometry-based chemical imaging: A noncontact continuous flow surface probe in mass spectrometry for enhanced signal detection and spatial resolution., Talanta, vol. 273, 125858, 2024 |
| 2024 |
Huang Han-Wen, Chen Chen-Chun, Lin Kuo-I, Hsu Tsui-Ling, Wong Chi-Huey, Single Site N-Glycosylation of B Cell Maturation Antigen (BCMA) Inhibits γ-Secretase-Mediated Shedding and Improves Surface Retention and Cell Survival, ACS Chemical Biology, vol. 19(1), 153-161, 2024 |
| 2024 |
Chen Nai-Yu, Lin Chih-Wei, Lai Ting-Yen, Wu Chung-Yi, Liao Pei-Chi, Hsu Tsui-Ling, Wong Chi-Huey, Increased expression of SSEA-4 on TKI-resistant non-small cell lung cancer with EGFR-T790M mutation, Proceedings of the National Academy of Sciences, vol. 121(5), e2313397121-e2313397121, 2024 |
| 2024 |
Lin Hsin-Hung, Wang Chun-Hsiung, Huang Shih-Hsin, Lin Sung-Yao, Kato Takayuki, Namba Keiichi, Hosogi Naoki, Song Chihong, Murata Kazuyoshi, Yen Ching-Hsuan, Hsu Tsui-Ling, Wong Chi-Huey, Wu Yi-Min, Tu I.-Ping, Chang Wei-Hau, Use of phase plate cryo-EM reveals conformation diversity of therapeutic IgG with 50 kDa Fab fragment resolved below 6 Å, Scientific Reports, vol. 14(1), 14079-14079, 2024 |
| 2024 |
Fan CY, Wang SW, Chung C, Chen JY, Chang CY, Chen YC, Hsu TL, Cheng TR, Wong CH, Synthesis of a dendritic cell-targeted self-assembled polymeric nanoparticle for selective delivery of mRNA vaccines to elicit enhanced immune responses., Chemical science, vol. 15(29), 11626-11632, 2024 |
| 2024 |
Kuo TY, Chang JC, (Chien YC, Jan CF*, The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study., Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 123(6), 693-700, 2024 |
| 2024 |
Fan CY, Wang SW, Chung C, Chen JY, Chang CY, Chen YC, Hsu TL, (Cheng TR, Wong CH*, Synthesis of a dendritic cell-targeted self-assembled polymeric nanoparticle for selective delivery of mRNA vaccines to elicit enhanced immune responses., Chemical science, vol. 15(29), 11626-11632, 2024 |
| 2024 |
Tseng YW, Yang TJ, Hsu YL, Liu JH, Tseng YC, Hsu TW, Lu Y, Pan SH, * (Cheng TR, *) Fang JM*, Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition., European journal of medicinal chemistry, vol. 265, 116042, 2024 |
| 2024 |
Wang CW, Tsai HY, Hsu C, Hsieh CC, Wang IS, (Chang CF, Su NW, Structure-specific metabolism of flavonol molecules by Bacillus subtilis var. natto BCRC 80517., Food chemistry, vol. 430, 136975, 2024 |
| 2024 |
Hsu PH, Hazam PK, Huang YP, Yeh JC, Chen YR, Li CC, (Chang CF, Liou JW, Chen JY, Sequential rearrangement and stereochemical reorganization to design an antimicrobial peptide with enhanced stability., Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 170, 116088, 2024 |
| 2024 |
Hsu PH, Hazam PK, Huang YP, Yeh JC, Chen YR, Li CC, (Chang CF, Liou JW, Chen JY, Optimization of sequence and chiral content enhances therapeutic potential of tilapia piscidin peptides., European journal of medicinal chemistry, vol. 265, 116083, 2024 |
| 2024 |
Tsai TY, Jhang WT, Hsu HK, Chan YT, (Chang CF, Chen YR, Amyloid Modifier SERF1a Accelerates Alzheimer's Amyloid-β Fibrillization and Exacerbates the Cytotoxicity., ACS chemical neuroscience, vol. 15(3), 479-490, 2024 |
| 2024 |
Lin GM, Yu TA, (Chang CF, Hsu CH, Proline Isomerization and Molten Globular Property of TgPDCD5 Secreted from Toxoplasma gondii Confers Its Regulation of Heparin Sulfate Binding., JACS Au, vol. 4(5), 1763-1774, 2024 |
| 2024 |
Lai CH, Ko KT, Fan PJ, Yu TA, (Chang CF, Draczkowski P, Hsu SD, Structural insight into the ZFAND1-p97 interaction involved in stress granule clearance., The Journal of biological chemistry, vol. 300(5), 107230, 2024 |
| 2024 |
Lin SM, Huang HT, Fang PJ, (Chang CF, Satange R, Chang CK, Chou SH, Neidle S, Hou MH, Structural basis of water-mediated cis Watson-Crick/Hoogsteen base-pair formation in non-CpG methylation., Nucleic acids research, vol. 52(14), 8566-8579, 2024 |
| 2024 |
Lin TC, Shih O, Tsai TY, Yeh YQ, Liao KF, Mansel BW, Shiu YJ, (Chang CF, Su AC, Chen YR, Jeng US, Binding structures of SERF1a with NT17-polyQ peptides of huntingtin exon 1 revealed by SEC-SWAXS, NMR and molecular simulation., IUCrJ, vol. 11(Pt 5), 849-858, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Response to Chen and Liaw., CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, vol. 15(3), e00663, 2024 |
| 2024 |
Chen YJ, Hsiao TH, Lin YC, Jeng WJ, Mao CL, Wei CY, Hsieh YC, Huang CJ, Pan MH, Chen IC, Lin CH, Chen YM, (Yang HI*, Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort., RMD OPEN, vol. 10(2), e003293, 2024 |
| 2024 |
Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, (Yang HI*, Chen CJ, Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(8), 993-1002, 2024 |
| 2024 |
Shen HC, Pan MH, Huang CJ, Yeh HY, (Yang HI*, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC, Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study., GENE, vol. 927, 148660, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(11), 1459-1461, 2024 |
| 2024 |
Lu TY, Wu CD, Huang YT, Chen YC, Chen CJ, (Yang HI, Pan WC*, Exposure to PM(2.5) Metal Constituents and Liver Cancer Risk in REVEAL-HBV., Journal of epidemiology, vol. 34(2), 87-93, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(12), 1618-1619, 2024 |
| 2024 |
Teng W, Chang TT, (Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC, Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines., HEPATOLOGY INTERNATIONAL, vol. 18(3), 1066, 2024 |
| 2024 |
Huang JF, Chang TJ, Yeh ML, Shen FC, Tai CM, Chen JF, Huang YH, Hsu CY, Cheng PN, Lin CL, Hung CH, Chen CC, Lee MH, Lee CC, Lin CW, Liu SC, (Yang HI, Chien RN, Kuo CS, Peng CY, Chang ML, Huang CF, Yang YS, Yang HC, Lin HC, Ou HY, Liu CJ, Tseng CH, Kao JH, Chuang WL, Huang CN, Chen PJ, Wang CY, Yu ML, Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus., HEPATOLOGY COMMUNICATIONS, vol. 8(11), e0571, 2024 |
| 2024 |
Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, (Yang HI, Chen HY, Chen CJ, Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC., CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. S1542-3565(24)00198-8, doi: 10.1016/j.cgh.2024.01.045, 2024 |
| 2024 |
Polaris Observatory Collaborators, (Yang HI); et al, Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories., Journal of hepatology, vol. 80(2), 232-242, 2024 |
